CA2609109A1 - Forms of factor xiia - Google Patents

Forms of factor xiia Download PDF

Info

Publication number
CA2609109A1
CA2609109A1 CA002609109A CA2609109A CA2609109A1 CA 2609109 A1 CA2609109 A1 CA 2609109A1 CA 002609109 A CA002609109 A CA 002609109A CA 2609109 A CA2609109 A CA 2609109A CA 2609109 A1 CA2609109 A1 CA 2609109A1
Authority
CA
Canada
Prior art keywords
factor xiia
disease
disorder
factor
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002609109A
Other languages
English (en)
French (fr)
Inventor
David John Pritchard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axis Shield Diagnostics Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2609109A1 publication Critical patent/CA2609109A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6451—Coagulation factor XIIa (3.4.21.38)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21038—Coagulation factor XIIa (3.4.21.38)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002609109A 2005-01-11 2006-01-10 Forms of factor xiia Abandoned CA2609109A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0500487.4 2005-01-11
GBGB0500487.4A GB0500487D0 (en) 2005-01-11 2005-01-11 Forms of factor XIIa
PCT/GB2006/000072 WO2006075142A2 (en) 2005-01-11 2006-01-10 FORMS OF FACTOR XIIa

Publications (1)

Publication Number Publication Date
CA2609109A1 true CA2609109A1 (en) 2006-07-20

Family

ID=34203898

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002609109A Abandoned CA2609109A1 (en) 2005-01-11 2006-01-10 Forms of factor xiia

Country Status (9)

Country Link
US (1) US20080274477A1 (enExample)
EP (1) EP1848799A2 (enExample)
JP (1) JP2008526937A (enExample)
CN (1) CN101180391A (enExample)
AU (1) AU2006205700A1 (enExample)
BR (1) BRPI0606307A2 (enExample)
CA (1) CA2609109A1 (enExample)
GB (1) GB0500487D0 (enExample)
WO (1) WO2006075142A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0607515D0 (en) * 2006-04-13 2006-05-24 Axis Shield Diagnostics Ltd Anti-factor xlla therapy
IL230564B2 (en) 2011-07-22 2023-09-01 Csl Ltd Anticoagulant monoclonal antibodies anti–factor xii/fxiia, a method for their preparation, a pharmaceutical compound containing them and medical uses.
WO2013190041A1 (en) * 2012-06-22 2013-12-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and kits for predicting the survival time of post acute myocardial infarction patients
CN104345154B (zh) * 2014-08-22 2016-10-26 北京蛋白质组研究中心 一种检测多肿瘤相关“多肽-蛋白组合式标志物”的双抗体夹心试剂盒
CN104177503B (zh) * 2014-08-22 2018-04-13 北京蛋白质组研究中心 一种激酶通路相关“多肽‑蛋白组合式”标志物及定量检测技术
CA2972800A1 (en) 2015-01-02 2016-07-07 Dyax Corp. Bispecific antibodies against plasma kallikrein and factor xii
EP3325516B1 (en) 2015-07-21 2021-12-15 Takeda Pharmaceutical Company Limited A monoclonal antibody inhibitor of factor xiia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901859D0 (en) * 1989-01-27 1989-03-15 Shield Diagnostics Limited Diagnostic test
EP1573339A2 (en) * 2002-12-20 2005-09-14 Axis-Shield Diagnostics Limited Detection or determination of variants of factor xiia

Also Published As

Publication number Publication date
US20080274477A1 (en) 2008-11-06
BRPI0606307A2 (pt) 2009-06-16
AU2006205700A1 (en) 2006-07-20
JP2008526937A (ja) 2008-07-24
CN101180391A (zh) 2008-05-14
WO2006075142A2 (en) 2006-07-20
WO2006075142A3 (en) 2006-09-14
GB0500487D0 (en) 2005-02-16
EP1848799A2 (en) 2007-10-31

Similar Documents

Publication Publication Date Title
US8741580B2 (en) Markers of renal transplant rejection and renal damage
CA2112702C (en) Assay methods and compositions for detecting serum proteases, particularly activated protein c
US20080038748A1 (en) Antibodies That Recognize Cutting Edge Within The Tgf-Beta Activation Controlling Region
AU2002245474B2 (en) Monitoring soluble endothelial protein C receptor levels in anticoagulant therapy
JPH09512630A (ja) 診断マーカーとしてのヒト好中球リポカリン（ｈｎｌ）の使用および抗−ｈｎｌ−抗体調製物
JP5860394B2 (ja) 新規モノクローナル抗体ならびにｄダイマーの免疫学的測定法
AU2002245474A1 (en) Monitoring soluble endothelial protein C receptor levels in anticoagulant therapy
JP6078845B2 (ja) 可溶型ｃｌｅｃ−２に基づく血小板活性化測定方法
CN103238072B (zh) 用于凝血酶检测的免疫测定法
JP5080707B2 (ja) 第ｖｉｉ因子活性化プロテアーゼの変異体および特異抗体を用いる検出方法
US20080274477A1 (en) Forms of Factor Xiia
Souri et al. Cloning of human anti-factor XIII monoclonal antibody dissects mechanisms of polyclonal antibodies in a single patient
JP5398697B2 (ja) 高分子量アディポネクチンの測定方法
US20250321239A1 (en) High-throughput method for lp(a)-cholesterol quantitation
JP2007278907A (ja) 動脈硬化マーカー蛋白質及びその用途
US20060024745A1 (en) Variants of factor XllA
JP4164804B2 (ja) 酒石酸抵抗性酸性ホスファターゼ５ｂに特異的なモノクローナル抗体およびその用途
US7045602B2 (en) Specific antibody directed to active hepatocyte growth factor activator and method for using the same
EP0251186B1 (en) Monoclonal antibody to human plasminogen, method for production thereof, assay reagent and kit comprising said antibody, and hybridoma producing said antibody
JP2008301833A (ja) 新規なモノクローナル抗体及びニックβ２グリコプロテインＩの免疫学的分析方法
JPH0694A (ja) 抗ヒトプラスミン−α２ −プラスミンインヒビター複合体特異抗体及び免疫学的測定法
JP2004061345A (ja) 尿中のプラスミノーゲンアクチベーターインヒビター−１測定による糖尿病性腎症の進展度の判定方法

Legal Events

Date Code Title Description
FZDE Discontinued